Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
+1,74%
1 094,84
+18,71
+1,74%
—1 076,131 079,891 100,771 079,89——
SIXC
Communications
SIXC
Communications
SIXC
-0,42%
604,21
-2,53
-0,42%
—606,74606,74607,90602,03——
SIXE
Energy
SIXE
Energy
SIXE
+0,07%
1 249,71
+0,89
+0,07%
—1 248,821 246,371 256,421 239,08——
SIXI
Industrials
SIXI
Industrials
SIXI
+0,86%
1 739,26
+14,90
+0,86%
—1 724,361 733,021 745,751 727,76——
SIXM
Financials
SIXM
Financials
SIXM
+0,01%
635,63
+0,040
+0,01%
—635,59635,08637,96633,31——
SIXR
Staples
SIXR
Staples
SIXR
+0,61%
848,32
+5,17
+0,61%
—843,15842,50852,77840,85——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
+0,22%
216,76
+0,47
+0,22%
—216,29216,29217,30215,24——
SIXT
Technology
SIXT
Technology
SIXT
+2,20%
3 335,14
+71,73
+2,20%
—3 263,413 296,253 343,663 295,42——
SIXU
Utilities
SIXU
Utilities
SIXU
+0,01%
939,34
+0,10
+0,01%
—939,24941,57948,11939,11——
SIXV
Health care
SIXV
Health care
SIXV
+0,38%
1 468,17
+5,61
+0,38%
—1 462,561 465,031 471,561 459,66——
SIXY
Discretionary
SIXY
Discretionary
SIXY
+0,28%
2 387,09
+6,69
+0,28%
—2 380,402 394,922 412,132 386,82——
Q1 2026 earnings • released • EPS beat +22,87% • Revenue beat +0,99%
See results
RGEN:NASDAQ
Repligen Corp
125,61 $
+6,26%
(+7,40) 1D
124,91 $
-0,56% (-0,70)
Pre-market
Closed: 5 մյս, 16:00:00 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for RGEN...
Open
121,24 $
High
128,31 $
Low
120,62 $
Mkt. cap
7,08 մլրդ
Avg. vol.
951,16 հզր
Volume
1,10 հզր
P/E ratio
145,31
52-wk high
175,77 $
52-wk low
109,50 $
EPS
0,86 $
Beta
1,09
Shares outstanding
56,40 մլն
No. of employees
2 հզր
News stories
From sources across the web
Profile
Repligen Corporation is a global life sciences company devoted to the development and commercialization of innovative bioprocessing technologies and systems that enable efficiencies in the process of manufacturing biological drugs. The company is based in Waltham, Massachusetts, and was incorporated in Delaware in 1981. A public company, Repligen is listed on the NASDAQ exchange under the symbol RGEN. As of 2025, Repligen employs over 1,900 employees globally and serves primarily biopharmaceutical drug developers and contract development and manufacturing organizations worldwide. Wikipedia
About Repligen Corp
CEOTony J. Hunt
Employees2 հզր
Founded1981
HeadquartersՈւոլթեմ, Մասսաչուսեթս, Միացյալ Նահանգներ
Sector-
Websiterepligen.com
Last report
05 մյս, 2026 թ.
Fiscal Period
Q1 2026
Normalized EPS / Estimate
0,48/ (0,39 est.)USD
+22,87%beat
Revenue / Estimate
194,26 մլն/ (192,35 մլն est.)USD
+0,99%beat
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
2025 թ. մրտ
2025 թ. հնս
2025 թ. սեպ
2025 թ. դեկ
Revenue
169,17 մլն
182,37 մլն
188,80 մլն
197,91 մլն
Cost of goods sold
77,80 մլն
89,37 մլն
88,29 մլն
94,08 մլն
Cost of revenue
77,80 մլն
89,37 մլն
88,29 մլն
94,08 մլն
Research and development expenses
12,11 մլն
13,97 մլն
14,18 մլն
13,12 մլն
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
69,81 մլն
69,41 մլն
73,66 մլն
74,36 մլն
Operating expense
81,92 մլն
83,38 մլն
87,84 մլն
87,48 մլն
Total operating expenses
159,72 մլն
172,75 մլն
176,13 մլն
181,56 մլն
Operating income
9,45 մլն
9,62 մլն
12,68 մլն
16,35 մլն
Other non operating income
-286,00 հզր
3,50 մլն
-446,00 հզր
-11,48 մլն
EBT including unusual items
7,94 մլն
18,22 մլն
17,11 մլն
19,11 մլն
EBT excluding unusual items
10,82 մլն
13,94 մլն
12,96 մլն
17,59 մլն
Income tax expense
2,11 մլն
3,35 մլն
2,20 մլն
5,83 մլն
Effective tax rate
26,60%
18,39%
12,86%
30,48%
Other operating expenses
-
-
-
-
Net income
5,83 մլն
14,87 մլն
14,91 մլն
13,29 մլն
Net profit margin
3,45%
8,15%
7,90%
6,71%
Earnings per share
0,39
0,37
0,46
0,49
Interest and investment income
7,31 մլն
6,58 մլն
6,92 մլն
6,75 մլն
Interest expense
-5,66 մլն
-5,77 մլն
-5,83 մլն
-5,91 մլն
Net interest expenses
1,65 մլն
817,00 հզր
1,09 մլն
842,00 հզր
Depreciation and amortization charges
-
-
-
-
EBITDA
28,16 մլն
29,70 մլն
32,69 մլն
36,30 մլն
Gain or loss from assets sale
1,22 մլն
2,16 մլն
-3,38 մլն
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer